Literature DB >> 17959663

Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.

Jangsuk Oh1, Kevin W Chang, Rafal Wierzchoslawski, W Gregory Alvord, Stephen H Hughes.   

Abstract

The sequences required for integration of retroviral DNA have been analyzed in vitro. However, the in vitro experiments do not agree on which sequences are required for integration: for example, whether or not the conserved CA dinucleotide in the 3' end of the viral DNA is required for normal integration. At least a portion of the problem is due to differences in the experimental conditions used in the in vitro assays. To avoid the issue of what experimental conditions to use, we took an in vivo approach. We made mutations in the 5' end of the U3 sequence of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z. We present evidence that, in RSV, the CA dinucleotide in the 5' end of U3 is not essential for appropriate integration. This result differs from the results seen with mutations in the U5 end, where the CA appears to be essential for proper integration in vivo. In addition, based on the structure of circular viral DNAs smaller than the full-length viral genome, our results suggest that there is little, if any, integrase-mediated autointegration of RSV linear DNA in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17959663      PMCID: PMC2224354          DOI: 10.1128/JVI.01441-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Substrate sequence selection by retroviral integrase.

Authors:  H Zhou; G J Rainey; S K Wong; J M Coffin
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.

Authors:  D Esposito; R Craigie
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

3.  Nucleotide sequence analysis of the long terminal repeat (LTR) of avian retroviruses: structural similarities with transposable elements.

Authors:  G Ju; A M Skalka
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

4.  Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions.

Authors:  R Dhar; W L McClements; L W Enquist; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

5.  The terminal nucleotides of retrovirus DNA are required for integration but not virus production.

Authors:  A T Panganiban; H M Temin
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

6.  Construction and characterization of a replication-competent retroviral shuttle vector plasmid.

Authors:  Jangsuk Oh; John G Julias; Andrea L Ferris; Stephen H Hughes
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Alternate polypurine tracts affect rous sarcoma virus integration in vivo.

Authors:  Jangsuk Oh; Kevin W Chang; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

8.  Alternate polypurine tracts (PPTs) affect the rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction.

Authors:  Kevin W Chang; John G Julias; W Gregory Alvord; Jangsuk Oh; Stephen H Hughes
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  A Rous sarcoma virus provirus is flanked by short direct repeats of a cellular DNA sequence present in only one copy prior to integration.

Authors:  S H Hughes; A Mutschler; J M Bishop; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

10.  Construction and analysis of deletion mutations in the pol gene of Moloney murine leukemia virus: a new viral function required for productive infection.

Authors:  P Schwartzberg; J Colicelli; S P Goff
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

View more
  7 in total

1.  Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.

Authors:  Jangsuk Oh; Kevin W Chang; Stephen H Hughes
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

Review 2.  HIV-1 reverse transcription.

Authors:  Wei-Shau Hu; Stephen H Hughes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

3.  Retroviral integrases promote fraying of viral DNA ends.

Authors:  Richard A Katz; George Merkel; Mark D Andrake; Heinrich Roder; Anna Marie Skalka
Journal:  J Biol Chem       Date:  2011-05-27       Impact factor: 5.157

4.  The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.

Authors:  Kevin W Chang; Jangsuk Oh; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

5.  Enhanced autointegration in hyperstable simian immunodeficiency virus capsid mutants blocked after reverse transcription.

Authors:  Christopher Tipper; Joseph Sodroski
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

Review 6.  Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs.

Authors:  Steven J Smith; Xue Zhi Zhao; Dario Oliveira Passos; Dmitry Lyumkis; Terrence R Burke; Stephen H Hughes
Journal:  Viruses       Date:  2021-01-29       Impact factor: 5.048

7.  Drug resistant integrase mutants cause aberrant HIV integrations.

Authors:  Janani Varadarajan; Mary Jane McWilliams; Bryan T Mott; Craig J Thomas; Steven J Smith; Stephen H Hughes
Journal:  Retrovirology       Date:  2016-09-29       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.